The global Cosentyx-drug Market is witnessing notable growth due to the increasing prevalence of autoimmune and inflammatory diseases such as plaque psoriasis, ankylosing spondylitis, and psoriatic arthritis. Cosentyx, a biologic drug to target interleukin-17A, has developed significant attention for its effectiveness in managing chronic inflammatory conditions with improved patient outcomes....